Study of Treatment for Posttraumatic Stress Disorder and Substance Use
| Status: | Completed |
|---|---|
| Conditions: | Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 10/14/2017 |
| Start Date: | January 2011 |
| End Date: | March 2015 |
Pilot Study of an Integrated Exposure-Based Model for Posttraumatic Stress Disorder and Substance Use Disorder
The purpose of this study is to determine if an integrated, cognitive-behavioral model of
psychotherapy is effective in the treatment of individuals with posttraumatic stress disorder
(PTSD) and substance use disorder (SUD) compared to a known evidence-based model for
PTSD/SUD.
psychotherapy is effective in the treatment of individuals with posttraumatic stress disorder
(PTSD) and substance use disorder (SUD) compared to a known evidence-based model for
PTSD/SUD.
This project is designed to evaluate a new model of psychotherapy that was developed for
individuals with PTSD and SUD. The new model helps them to explore the past as a step in
their recovery process. It has major public health relevance in that it is a low-cost,
flexible model designed for all trauma and substance abuse types, both genders, and all
clinical settings. It has particular relevance for VA in that many veterans suffer from PTSD
and SUD. The new model has demonstrated positive results in two pilot studies. If the results
of the current study are positive, a larger study could be done for the next stage of
scientific testing.
individuals with PTSD and SUD. The new model helps them to explore the past as a step in
their recovery process. It has major public health relevance in that it is a low-cost,
flexible model designed for all trauma and substance abuse types, both genders, and all
clinical settings. It has particular relevance for VA in that many veterans suffer from PTSD
and SUD. The new model has demonstrated positive results in two pilot studies. If the results
of the current study are positive, a larger study could be done for the next stage of
scientific testing.
Inclusion Criteria:
- Meet Diagnostic and Statistical Manual (DSM-IV) criteria for current PTSD and current
substance use disorder
- Have used a substance in the 60 days prior to intake
- Outpatient
- Plan to stay in Boston for the next 6 months
- If on psychiatric medication, are on a stable regimen for at least 4 weeks prior to
participation in the study
- Have a stable mailing address and live nearby enough to come to VA Boston for
treatment
- Able to sign informed consent
- Willing to participate in all assessments and urine testing
- Willing to provide a release of information for study staff to contact treaters as
needed for clinical concerns
Exclusion Criteria:
- Any current acute medical condition that would either interfere with the patient's
ability to attend treatment, or would be of such severity as to affect the patient's
psychological functioning
- Current bipolar I disorder, schizophrenia or other psychotic disorders, mental
retardation, or organic mental disorder
- Any obvious clinical sign that the patient is not sufficiently stable to participate
in the treatment, or notification by the patient's primary providers that
participation would be contraindicated
- Dangerousness that would present a threat to staff or patients (e.g., history of
assault within the past 6 months)
- The patient is mandated to treatment
We found this trial at
1
site
Click here to add this to my saved trials
